Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zynerba Pharma CS (ZYNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 141,295
  • Shares Outstanding, K 13,560
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,010 K
  • 36-Month Beta 4.87
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.81

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.43 +6.46%
on 07/20/18
12.50 -36.72%
on 06/22/18
-3.97 (-33.42%)
since 06/20/18
3-Month
7.43 +6.46%
on 07/20/18
12.50 -36.72%
on 06/22/18
-2.65 (-25.09%)
since 04/20/18
52-Week
5.42 +45.94%
on 08/14/17
19.15 -58.69%
on 07/21/17
-10.90 (-57.95%)
since 07/20/17

Most Recent Stories

More News
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. All of the shares...

ZYNE : 7.91 (-24.09%)
Recreational Cannabis Sales Will Rise Domestically and Abroad

According to the data provided by Energias Market Research, the global medical cannabis market is expected to increase from USD 8.28 Billion in 2017 to USD 28.07 Billion in 2024, and at a CAGR of 19.1%...

KSHB : 4.7300 (+2.38%)
APHQF : 7.9380 (-2.00%)
WDDMF : 1.1090 (-1.68%)
WMD.VN : 1.430 (-4.67%)
TRTC : 1.7900 (+1.70%)
ZYNE : 7.91 (-24.09%)
Tax Revenues from Cannabis Sales are Expected to Climb Even Further

According to a report published by the research firm Cowen & Co., the U.S. legal cannabis industry is expected to reach USD 75 Billion in sales by 2030. The research clarifies that the increasing consumer...

KSHB : 4.7300 (+2.38%)
IVITF : 1.0252 (+2.52%)
ACBFF : 5.6400 (-2.76%)
WDDMF : 1.1090 (-1.68%)
WMD.VN : 1.430 (-4.67%)
ZYNE : 7.91 (-24.09%)
Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial of ZYN002 in Fragile X Syndrome

Study will Evaluate the Efficacy and Safety of Transdermally-Delivered Cannabidiol (CBD) in Children and Adolescents with Fragile X Syndrome

ZYNE : 7.91 (-24.09%)
Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced top line results...

ZYNE : 7.91 (-24.09%)
Data Projects that Cannabis Legalization Will Continue to Create Vast Monetary Value

According to data provided by the European investment bank, Bryan, Garnier & Co., the legal global cannabis market is expected to grow more than 1,000% over the next decade and could reach USD 140 Billion...

POTND : 0.0200 (+32.45%)
WDDMF : 1.1090 (-1.68%)
XXII : 2.49 (-3.11%)
WMD.VN : 1.430 (-4.67%)
TRTC : 1.7900 (+1.70%)
POTN : 0.2977 (-0.80%)
ZYNE : 7.91 (-24.09%)
The Growth of Legal Cannabis Markets are Exceeding Expectations

According to data reported by Arcview Market Research, consumer spending on legal cannabis in North America is outpacing previous estimates. The report emphasizes that retail cannabis sales will grow 33%...

CRON : 6.54 (-4.25%)
RLTY.CN : 0.750 (+2.74%)
CVSI : 1.9600 (+2.08%)
ZYNE : 7.91 (-24.09%)
TGODF : 4.4100 (unch)
Cannabis Sales are Expected to Increase on a Global Stage

A market report by Arcview Market Research, in partnership with BDS Analytics, predicts that adult-use cannabis spending will account for USD 38.3 Billion, while medical spending will reach USD 19.1 Billion....

IIPR : 32.91 (-0.96%)
WDDMF : 1.1090 (-1.68%)
GWPH : 146.22 (-1.61%)
WMD.VN : 1.430 (-4.67%)
ZYNE : 7.91 (-24.09%)
CGC : 24.31 (-4.37%)
International Cannabis Legalization to Spur Global Medical and Recreational Sales

According to a research report provided by European investment bank, Bryan, Garnier & Co., the legal global cannabis market is expected to grow more than 1,000% over the next decade and could reach USD...

CARA : 19.06 (-1.04%)
RVV.VN : 0.180 (-7.69%)
WDDMF : 1.1090 (-1.68%)
GWPH : 146.22 (-1.61%)
XXII : 2.49 (-3.11%)
WMD.VN : 1.430 (-4.67%)
ZYNE : 7.91 (-24.09%)
RVVTF : 0.1370 (-2.56%)
New Tech Could Transform the $60B Marijuana Industry

FN Media Group Presents OilPrice.com News Commentary

IIPR : 32.91 (-0.96%)
INSY : 7.83 (-5.55%)
ABBV : 88.91 (-1.16%)
ZYNE : 7.91 (-24.09%)
CODI : 17.35 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

See More Share

Trade ZYNE with:

Business Summary

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal...

See More

Key Turning Points

2nd Resistance Point 8.52
1st Resistance Point 8.22
Last Price 7.91
1st Support Level 7.52
2nd Support Level 7.12

See More

52-Week High 19.15
Fibonacci 61.8% 13.91
Fibonacci 50% 12.28
Fibonacci 38.2% 10.66
Last Price 7.91
52-Week Low 5.42

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar